Target species
Pigs (for fattening)
Indications for use for each target species
For the active immunisation of pigs to reduce:
- viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection,
- severity of lung lesions caused by Mycoplasma hyopneumoniae infection,
- the loss in body weight gain.
Onset of immunity:
PCV2: 2 weeks after vaccination
M. hyopneumoniae: 3 weeks after vaccination
Duration of immunity:
PCV2: 23 weeks after vaccination
M. hyopneumoniae: 23 weeks after vaccination
Contraindications
None.
Special warnings
Vaccinate healthy animals only. In farms where PCV2 and M. hyopneumoniae vaccination of sows and gilts is performed during their late pregnancy and the high levels of MDA can be expected, the use of Cirbloc M Hyo may be delayed.
Special precautions for use
Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this veterinary medicinal product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Special precautions for the protection of the environment:
Not applicable.
Adverse events
Pigs (for fattening):
Very common (>1 animal / 10 animals treated): | Injection site swelling1 |
Very common (>1 animal / 10 animals treated): | Elevated temperature2 Lethargy2 |
1 Swellings of 0.2 cm to 2 cm diameter might occur when administration is performed with mass injector; they disappear spontaneously within nine days.
2 Lethargy and increase in body temperature can occur four hours after vaccination, with a maximum of 1.7 °C at individual level and 0.5-0.78 °C as an average, resolving spontaneously by the next day.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing 4 authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during pregnancy or lactation.
Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Administration routes and dosage Intramuscular use.
Vaccinate pigs in the neck. A single dose of 2 ml is given to pigs from 3 weeks of age onwards.
Allow it to reach room temperature (15 °C – 25 °C). Shake well before use. Apply usual aseptic procedures.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
No data available.
Withdrawal periods
Zero days